Jpmorgan Chase & CO Glaukos Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Glaukos Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 583,048 shares of GKOS stock, worth $55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
583,048
Previous 400,586 45.55%
Holding current value
$55 Million
Previous $60.1 Million 4.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$96.6 - $161.22 $17.6 Million - $29.4 Million
182,462 Added 45.55%
583,048 $57.4 Million
Q4 2024

Feb 12, 2025
BUY
$126.42 - $152.67 $5.22 Million - $6.3 Million
41,269 Added 11.49%
400,586 $60.1 Million
Q3 2024

Dec 26, 2024
BUY
$113.62 - $135.39 $14.2 Million - $16.9 Million
125,035 Added 53.37%
359,317 $46.8 Million
Q3 2024

Nov 08, 2024
BUY
$113.62 - $135.39 $14.2 Million - $16.9 Million
125,035 Added 53.37%
359,317 $46.8 Million
Q2 2024

Dec 26, 2024
SELL
$89.48 - $118.35 $11.2 Million - $14.8 Million
-125,035 Reduced 34.8%
234,282 $27.7 Million
Q2 2024

Aug 12, 2024
BUY
$89.48 - $118.35 $12.9 Million - $17.1 Million
144,516 Added 160.99%
234,282 $27.7 Million
Q1 2024

Dec 26, 2024
SELL
$76.4 - $96.33 $20.6 Million - $26 Million
-269,551 Reduced 75.02%
89,766 $8.46 Million
Q1 2024

May 10, 2024
SELL
$76.4 - $96.33 $2.6 Million - $3.28 Million
-34,046 Reduced 27.5%
89,766 $8.46 Million
Q4 2023

Dec 26, 2024
SELL
$59.53 - $85.11 $14 Million - $20 Million
-235,505 Reduced 65.54%
123,812 $9.84 Million
Q4 2023

Feb 12, 2024
BUY
$59.53 - $85.11 $1.17 Million - $1.67 Million
19,641 Added 18.85%
123,812 $9.84 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $78,091 - $89,213
-1,128 Reduced 1.07%
104,171 $7.84 Million
Q2 2023

Aug 11, 2023
BUY
$45.44 - $71.21 $516,334 - $809,159
11,363 Added 12.1%
105,299 $7.5 Million
Q1 2023

May 18, 2023
BUY
$43.88 - $52.48 $2.56 Million - $3.07 Million
58,412 Added 164.43%
93,936 $4.71 Million
Q1 2023

May 11, 2023
SELL
$43.88 - $52.48 $5.44 Million - $6.5 Million
-123,940 Reduced 77.72%
35,524 $1.78 Million
Q4 2022

Feb 13, 2023
SELL
$40.82 - $57.75 $1.66 Million - $2.35 Million
-40,697 Reduced 20.33%
159,464 $6.97 Million
Q3 2022

Nov 14, 2022
BUY
$46.84 - $58.49 $2.52 Million - $3.14 Million
53,739 Added 36.7%
200,161 $10.7 Million
Q2 2022

Aug 11, 2022
BUY
$34.86 - $63.77 $63,758 - $116,635
1,829 Added 1.26%
146,422 $6.65 Million
Q1 2022

May 11, 2022
BUY
$44.33 - $57.82 $1.35 Million - $1.76 Million
30,519 Added 26.75%
144,593 $8.36 Million
Q4 2021

Feb 10, 2022
SELL
$40.27 - $56.99 $415,868 - $588,535
-10,327 Reduced 8.3%
114,074 $5.07 Million
Q3 2021

Nov 12, 2021
BUY
$47.43 - $84.23 $5.9 Million - $10.5 Million
124,401 New
124,401 $5.99 Million

Others Institutions Holding GKOS

# of Institutions
358
Shares Held
50.2M
Call Options Held
260K
Put Options Held
776K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.49B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email